Phase 3 SHORELINE Study evaluating SAGE-217 open-label treatment, treatment-free intervals and as-needed retreatment for return of major depressive episodes. Data from Part A open-label portion of the ...
“We’re quickly moving from the Age of Information to an Age of Answers. From embedding machine-learning and artificial intelligence capabilities directly into our general ledger to streamlining the ...
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks ...
Top Annualised Recurring Revenue (ARR) growth year-over-year Top revenue growth year-over-year for products within Sage Business Cloud. In addition to being the recipient of this much sought-after ...
Sage Therapeutics Announces Planned Progression of SAGE-718 to Phase 2 in Huntington's Disease and Presentations at the 2019 Annual Meeting of the American College of Neuropsychopharmacology (ACNP) ...
China-based IC design firm Sage Microelectronics Corp. (Sage Micro) completed the acquisition of Beijing-based ChuZhi for US$18 million (CNY125 million) during the last week of 2019. According to Sage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results